Behavioral strategies become especially important during weaning
Tranexamic acid (when included) adds a further dimension by inhibiting melanin synthesis through a mechanism that is independent of glutathione
Data collected during the probe trials (time spent in the target quadrant and entries into the target quadrant) were also analyzed using one-way ANOVAs
Everyday activities can be done without difficulty
Previously, the only FDA-approved therapy for MASH was Madrigal Pharma's THR -selective agonist Rezdiffra (resmetirom), which was cleared in the US last year and looks to be on a path to blockbuster status, with sales reaching around $350 million in the first half of this year
During the March 2025 MDL status conference, plaintiffs lead counsel advised Judge Karen Spencer Marston that the litigation could ultimately involve thousands, or even tens of thousands, of cases